title: Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk.
abstract: Genome-wide association studies have identified a SNP, rs2294008, on 8q24.3 within the prostate stem cell antigen (PSCA) gene, as a risk factor for bladder cancer. To fine-map this region, we imputed 642 SNPs within 100 Kb of rs2294008 in addition to 33 markers genotyped in one of the reported genome-wide association study in 8,652 subjects. A multivariable logistic regression model adjusted for rs2294008 revealed a unique signal, rs2978974 (r(2) = 0.02, D' = 0.19 with rs2294008). In the combined analysis of 5,393 cases and 7,324 controls, we detected a per-allele odds ratio (OR) = 1.11 [95% confidence interval (CI) = 1.06-1.17, P = 5.8 × 10(-5)] for rs2294008 and OR = 1.07 (95% CI = 1.02-1.13, P = 9.7 × 10(-3)) for rs2978974. The effect was stronger in carriers of both risk variants (OR = 1.24, 95% CI = 1.08-1.41, P = 1.8 × 10(-3)) and there was a significant multiplicative interaction (P = 0.035) between these two SNPs, which requires replication in future studies. The T risk allele of rs2294008 was associated with increased PSCA mRNA expression in two sets of bladder tumor samples (n = 36, P = 0.0007 and n = 34, P = 0.0054) and in normal bladder samples (n = 35, P = 0.0155), but rs2978974 was not associated with PSCA expression. SNP rs2978974 is located 10 Kb upstream of rs2294008, within an alternative untranslated first exon of PSCA. The non-risk allele G of rs2978974 showed strong interaction with nuclear proteins from five cell lines tested, implying a regulatory function. In conclusion, a joint effect of two PSCA SNPs, rs2294008 and rs2978974, suggests that both variants may be important for bladder cancer susceptibility, possibly through different mechanisms that influence the control of mRNA expression and interaction with regulatory factors.
authors.affiliation: Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
authors.forename: Yi-Ping
authors.initials: YP
authors.lastname: Fu
authors.forename: Indu
authors.initials: I
authors.lastname: Kohaar
authors.forename: Nathaniel
authors.initials: N
authors.lastname: Rothman
authors.forename: Julie
authors.initials: J
authors.lastname: Earl
authors.forename: Jonine D
authors.initials: JD
authors.lastname: Figueroa
authors.forename: Yuanqing
authors.initials: Y
authors.lastname: Ye
authors.forename: Núria
authors.initials: N
authors.lastname: Malats
authors.forename: Wei
authors.initials: W
authors.lastname: Tang
authors.forename: Luyang
authors.initials: L
authors.lastname: Liu
authors.forename: Montserrat
authors.initials: M
authors.lastname: Garcia-Closas
authors.forename: Brian
authors.initials: B
authors.lastname: Muchmore
authors.forename: Nilanjan
authors.initials: N
authors.lastname: Chatterjee
authors.forename: McAnthony
authors.initials: M
authors.lastname: Tarway
authors.forename: Manolis
authors.initials: M
authors.lastname: Kogevinas
authors.forename: Patricia
authors.initials: P
authors.lastname: Porter-Gill
authors.forename: Dalsu
authors.initials: D
authors.lastname: Baris
authors.forename: Adam
authors.initials: A
authors.lastname: Mumy
authors.forename: Demetrius
authors.initials: D
authors.lastname: Albanes
authors.forename: Mark P
authors.initials: MP
authors.lastname: Purdue
authors.forename: Amy
authors.initials: A
authors.lastname: Hutchinson
authors.forename: Alfredo
authors.initials: A
authors.lastname: Carrato
authors.forename: Adonina
authors.initials: A
authors.lastname: Tardón
authors.forename: Consol
authors.initials: C
authors.lastname: Serra
authors.forename: Reina
authors.initials: R
authors.lastname: García-Closas
authors.forename: Josep
authors.initials: J
authors.lastname: Lloreta
authors.forename: Alison
authors.initials: A
authors.lastname: Johnson
authors.forename: Molly
authors.initials: M
authors.lastname: Schwenn
authors.forename: Margaret R
authors.initials: MR
authors.lastname: Karagas
authors.forename: Alan
authors.initials: A
authors.lastname: Schned
authors.forename: W Ryan
authors.initials: WR
authors.lastname: Diver
authors.forename: Susan M
authors.initials: SM
authors.lastname: Gapstur
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Thun
authors.forename: Jarmo
authors.initials: J
authors.lastname: Virtamo
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Chanock
authors.forename: Joseph F
authors.initials: JF
authors.lastname: Fraumeni
authors.forename: Debra T
authors.initials: DT
authors.lastname: Silverman
authors.forename: Xifeng
authors.initials: X
authors.lastname: Wu
authors.forename: Francisco X
authors.initials: FX
authors.lastname: Real
authors.forename: Ludmila
authors.initials: L
authors.lastname: Prokunina-Olsson
mesh_terms: D000951:Antigens, Neoplasm / Q000235:genetics* / Q000378:metabolism; D045744:Cell Line, Tumor; D004273:DNA, Neoplasm / Q000378:metabolism; D024202:Electrophoretic Mobility Shift Assay; D058851:GPI-Linked Proteins / Q000235:genetics / Q000378:metabolism; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D056726:Genetic Association Studies; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D006801:Humans; D009363:Neoplasm Proteins / Q000235:genetics* / Q000378:metabolism; D020161:Physical Chromosome Mapping; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011485:Protein Binding; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D011995:Recombination, Genetic / Q000235:genetics; D012307:Risk Factors; D017423:Sequence Analysis, RNA; D001749:Urinary Bladder Neoplasms / Q000235:genetics*
chemical_list: D000951:Antigens, Neoplasm; D004273:DNA, Neoplasm; D058851:GPI-Linked Proteins; D005819:Genetic Markers; D009363:Neoplasm Proteins; C110843:PSCA protein, human; D020033:Protein Isoforms; D012333:RNA, Messenger